French firm Sanofi to help produce 100 million Pfizer BioNTech vaccine doses for Covid 19


 

 

 

Germany located BioNTech will initially produce the vaccines at Sanofi facilities in Frankfurt, starting in the summer, according to a Sanofi statement Wednesday. The company did not reveal financial details of the agreement.

The French government has been pressing Sanofi to use its facilities to help make rival vaccines, given high demand and problems with supplies of the few vaccines that are already available.

According to Thomas Cueni, director of the International Federation of Vaccine Manufacturers, 76% of the world’s major vaccine manufacturing capacity is in Europe.

The French government has pressed Sanofi to use its facilities to help make vaccines from its rivals, given the high demand and supply problems.

“We are very conscious that the earlier vaccine doses are available, the more lives can potentially be saved,” Sanofi CEO Paul Hudson said in a statement.

 


Follow us on Google news for more updates and News










Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.


CWEB.com is not registered as an investment adviser with the U.S. Securities and Exchange Commission. Rather, CWEB.com relies upon the “publisher’s exclusion” from the definition of investment adviser as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

Full Disclaimer